Online customer service
Customer service hotline
Customer service team:
在线客服
Skype
Wangwang:
QQ:
Service time:
8:00 - 17:00

National Advisory Hotline

400-8536-777

Add: No. 17, Tianjin North Road, Yantai Development Zone

Copyright © 2020 Yantai Huaxin Biomedical Science and Technology Co., Ltd

Lu ICP No.14008762 Powered by 300.cn

Huaxin Biomedical

WeChat

Huaxin Biomedical

Mobile official website

Yantai Huaxin Biomedical Science and Technology Co., Ltd

>
>
Wu Chunfu

Wu Chunfu

Page view
[Abstract]:
◇ Former Party Secretary and President of Shenyang Pharmaceutical University
◇ Doctoral supervisor
◇ Vice Chairman of Chinese Pharmaceutical Association, Supervisor of Chinese Pharmaceutical Association

Wu Chunfu, male, doctor, professor. Graduated from Shenyang College of Pharmacy in 1982. In 1987, he obtained the certificate of pharmacology research expert in Lombardi Region, Italy, and the doctorate degree of Hokkaido University of Pharmacy in Japan in 2000. In 1985, he went to the Mario Negri Institute of Pharmacology in Italy to study neuropharmacology. In 2002, 2004, 2006 and 2008, he went to Harvard University in the United States, Oxford University in the United Kingdom, the University of Michigan in the United States, and the University of Toronto in Canada to study government management, education management and other courses. In 1982, he stayed at the school to teach. He was promoted to associate professor and professor twice in 1992 and 1994 respectively. In 1996, he was named a doctoral supervisor. In 1996, he served as the executive vice president of Shenyang Pharmaceutical University, the president in 2000, the party secretary and president in 2010, and the school party secretary from 2011 to 2018. He is currently the vice chairman of the Chinese Pharmaceutical Association and a supervisor of the Chinese Pharmacological Association. National “Twelfth Five-Year” and “Thirteenth Five-Year” National New Drug Development Major Special Expert Group Experts, National “Eleventh Five-Year” and “Twelfth Five-Year” Major New Drug Creation Projects Liaoning Province New Drug Creation Comprehensive Platform, 863 Project, Multiple The person in charge of the National Natural Science Foundation of China's key and general projects, the key laboratory of the State Administration of Traditional Chinese Medicine, the New Drug Screening Laboratory of Liaoning Province, and the Key Laboratory of New Drug Efficacy Evaluation of Liaoning Province. The main research areas involve neuropsychopharmacology, Chinese medicine and compound pharmacology, tumor molecular biology, etc. More than 300 articles have been published in SCI journals such as Nature Nanotechnololgy, Proc. Natl. Acad. Sci. USA, Pharmacology Therapeutics, Cancer Letter, Free Radical Biology Medicine, Neurobiol. Aging. He has been listed as a highly cited Chinese scholar in Elsvier pharmacy and pharmacology for 6 consecutive years. Editor-in-chief of "Introduction to Pharmacy", "Modern Geriatric Pharmacy", "Introduction to Sub-health and Health Food" and other works. Won more than 10 Chinese invention patents.

He has won the National Candidate of New Century Tens and Millions (2004), the Contact Expert of the Organization Department of the Central Committee, the Special Allowance of the State Council, the Second Prize of National Teaching Achievement (2010), the First Prize of Liaoning Province Science and Technology Progress Award (2010) Paul Yangsen-Wu Jieping The Second Prize of Geriatric Pharmacy (2004), the 11th Wu Jieping~Paul Janssen Pharmaceutical Research Award (2010). He has served as a judge of the National Science and Technology Progress Award, a member of the New Drug Review of the State Food and Drug Administration, and a member of the National Food and Drug Administration of Chinese Medicine Protected Variety Review.

He is the editor-in-chief of Asian Journal of Traditional medicines, deputy editor-in-chief of Chinese Natural Drugs and Chinese Herbal Medicine, and editorial board member of Pharmacology, Bioichemistry and Behavior, International Immunopharmacology, Acta Pharmacologica Sinica, Indian Journal of Pharmacognosy, etc.

Previous article:
Next article: